Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
暂无分享,去创建一个
Wen Zheng | Qianhui Wu | Juan Yang | Hongjie Yu | K. Chu | F. Zhu | W. Yin | H. Pan | Lin Wang | Yuliang Zhao | G. Zeng | Wanying Lu | Zhiwei Wu | Minjie Li | Lei Wang | B. Han | D. Jiang | Lin Wang | X. Deng | Hongjie Yu